Genome editing in animals: why FDA regulation matters

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Template plasmid integration at the target site of genome-edited animals.

References

  1. 1.

    Norris, A. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-019-0394-6 (2020).

  2. 2.

    Carlson, D. F. et al. Nat. Biotechnol. 34, 479–481 (2016).

  3. 3.

    Nagahata, H. J. Vet. Med. Sci. 66, 1475–1482 (2004).

  4. 4.

    Shuster, D. E., Kehrli, M. E. Jr., Ackermann, M. R. & Gilbert, R. O. Proc. Natl Acad. Sci. USA 89, 9225–9229 (1992).

  5. 5.

    Kumar, V. & Sharma, A. Agric. Rev. (Karnal) 30, 293–300 (2009).

  6. 6.

    Olson, E. N., Arnold, H.-H., Rigby, P. W. & Wold, B. J. Cell 85, 1–4 (1996).

  7. 7.

    Meier, I. D. et al. FASEB J. 24, 1714–1724 (2010).

Download references

Author information

Correspondence to Steven M. Solomon.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Solomon, S.M. Genome editing in animals: why FDA regulation matters. Nat Biotechnol 38, 142–143 (2020). https://doi.org/10.1038/s41587-020-0413-7

Download citation